Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8819 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.869 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.86 |
High Similarity |
NPD7819 |
Suspended |
0.8582 |
High Similarity |
NPD1510 |
Phase 2 |
0.8553 |
High Similarity |
NPD7075 |
Discontinued |
0.8543 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8531 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8429 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8414 |
Intermediate Similarity |
NPD3750 |
Approved |
0.84 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8366 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8291 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8264 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8235 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8188 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8188 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8138 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8121 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8101 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8095 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8077 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8069 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8039 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8014 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8014 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8014 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8013 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7919 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD943 |
Approved |
0.7902 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7872 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7843 |
Intermediate Similarity |
NPD920 |
Approved |
0.7815 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD2797 |
Approved |
0.78 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7771 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7673 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7651 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1201 |
Approved |
0.764 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD9545 |
Approved |
0.76 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7597 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7591 |
Intermediate Similarity |
NPD9493 |
Approved |
0.759 |
Intermediate Similarity |
NPD7472 |
Approved |
0.759 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7562 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7552 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7534 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5402 |
Approved |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD919 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7465 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD7003 |
Approved |
0.744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7397 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7351 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7288 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7259 |
Intermediate Similarity |
NPD74 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD17 |
Approved |
0.7218 |
Intermediate Similarity |
NPD5909 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4287 |
Approved |
0.72 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7185 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7185 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7115 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7113 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD8312 |
Approved |
0.711 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7103 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7067 |
Intermediate Similarity |
NPD411 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7063 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD37 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7039 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD4966 |
Approved |
0.703 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7015 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7015 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6972 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4477 |
Approved |
0.6968 |
Remote Similarity |
NPD4476 |
Approved |
0.6954 |
Remote Similarity |
NPD6798 |
Discontinued |
0.695 |
Remote Similarity |
NPD9281 |
Approved |
0.695
|
Remote Similarity |
NPD5951 |
Approved |